Trastuzumab

Strength: 440 mg/vial

Dosage Form: Powder for injection

Description:

Trastuzumab is a monoclonal antibody targeting HER2 receptors, used in HER2-positive breast and gastric cancers. It inhibits tumor cell proliferation.

Key Features:

• Targets HER2-positive tumors specifically
• Enhances survival in breast cancer patients
• Requires IV infusion after reconstitution

Precautions:

Monitor cardiac function closely. Risk of infusion reactions.